Skip to main content

Cranberry Products Can Reduce Risk for Symptomatic UTIs

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

MONDAY, May 8, 2023 -- Cranberry products reduce the risk for symptomatic, culture-verified urinary tract infections (UTIs), especially in specific populations, according to a review published online April 17 in the Cochrane Library.

Gabrielle Williams, Ph.D., M.P.H., from The Children's Hospital at Westmead in Australia, and colleagues examined the effectiveness of cranberry products in preventing UTI in susceptible populations. Twenty-six studies were added for this update, resulting in 50 included studies with 8,857 randomly assigned participants. A total of 45 studies compared cranberry products to placebo or no specific treatment; 26 of these could be meta-analyzed.

The researchers found that cranberry products reduced the risk for UTIs based on moderate-certainty evidence (risk ratio, 0.70). When studies were categorized according to treatment indication, cranberry products reduced the risk for symptomatic, culture-verified UTIs in women with recurrent UTIs, children, and those with a susceptibility to UTIs due to an intervention (risk ratios, 0.74, 0.46, and 0.47, respectively). Little or no benefit was seen in elderly institutionalized men and women, pregnant women, or adults with neuromuscular bladder dysfunction with incomplete bladder emptying (based on low-certainty evidence).

"This is a review of the totality of the evidence and as new evidence emerges, new findings might occur," a coauthor said in a statement. "In this case, the new evidence shows a very positive finding that cranberry juice can prevent UTI in susceptible people."

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted May 2023

Read this next

FDA Approves New Antibiotic, Pivya, for Uncomplicated Urinary Tract Infections

TUESDAY, April 30, 2024 -- The U.S. Food and Drug Administration has approved Pivya (pivmecillinam) tablets for the treatment of female adults with uncomplicated urinary tract...

Computer Prompts Could Reduce Empiric Antibiotic Use for UTI

FRIDAY, April 19, 2024 -- For non-critically ill patients with urinary tract infection (UTI), computerized provider order entry (CPOE) prompts providing patient- and...

Obstructive Sleep Apnea Linked to Bladder Pain/Interstitial Cystitis

THURSDAY, March 7, 2024 -- Obstructive sleep apnea (OSA) seems to be associated with bladder pain syndrome/interstitial cystitis (BPS/IC) in women, according to a study published...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.